Gastroenterology Clinical Trials List

Title:

Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study To Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications in Patients with Early Decompensated Liver Cirrhosis

Type of Disease:

Cirrhosis

Locations Available:

NYU Langone Medical Center
Hepatology Associates
530 First Avenue, Suite 4J
New York, NY 10016

Principal Investigator:

Samuel Sigal, MD

Contact:

Therese Capobianco

BACK

Return to the Gastroenterology Clinical Trials List.